DOON VALLEY PHARMACY LIMITEDActive

Company number SC354883Private limited companyIncorporated 2009

Key figures

£1,810,013+1.1%
Net assets 2024/25
+4.0%
Average annual growth 2019/20–2024/25
0500 k1 m1.5 m2 m2019/202020/212021/222023/242024/25

Like most small UK companies, DOON VALLEY PHARMACY LIMITED does not publish a profit and loss account in its latest accounts. The figures below come from the balance sheet.

Ratios

2024/25
Balance sheet structure
Current assetsFixed assetsLiabilitiesNet assets
01 m2 m3 m2019/202020/212021/222023/242024/25
Filed accounts2019/20–2024/25
2019/202020/212021/222023/242024/25
Cash at bank and in hand42,70626,95489,0846,751200
Total assets1,838,6611,955,5031,920,6182,038,0652,081,478
Total liabilities————263,666
Net assets / total equity1,544,9001,673,8601,691,0411,789,9291,810,013
Average number of employees111010120

A dash (—) means no accounts were filed for that year or the item is not in the accounts; 0 is a zero stated in the accounts. Small companies usually file only a balance sheet, so the profit and loss account is often missing.

Summary: DOON VALLEY PHARMACY LIMITED

Company

DOON VALLEY PHARMACY LIMITED is a private limited company registered with Companies House under company number SC354883. It was incorporated on 11 Feb 2009. Its status is active. The registered office is in Glasgow (G43). Its nature of business (SIC 2007) is dispensing chemist in specialised stores (47730).

Accounts

The latest accounts in the database are for 2024/25 (period ending 31 Mar 2025); the company files small company accounts (filleted). Net assets were £1,810,013, up 1.1% on the previous year. Cash at bank and in hand was £200. Total assets were £2,081,478 and total liabilities £263,666. The company had an average of 0 employees. Figures are available for 5 financial years (2019/20–2024/25).

Control and charges

One person with significant control is registered. 1 of 5 registered charges are outstanding.

Filing deadlines

The next accounts are due by 31 Dec 2026. The next confirmation statement is due by 6 Nov 2026.